López-Sánchez Marta, Rubio-López María Isabel
Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, España.
Rev Bras Ter Intensiva. 2020 Mar;32(1):143-148. doi: 10.5935/0103-507x.20200020. Epub 2020 May 8.
In recent years and due, in part, to technological advances, the use of extracorporeal carbon dioxide removal systems paired with the use of extracorporeal membrane oxygenation has resurfaced. However, studies are lacking that establish its indications and evidence to support its use. These systems efficiently eliminate carbon dioxide in patients with hypercapnic respiratory failure using small-bore cannula, usually double-lumen cannula with a small membrane lung surface area. Currently, we have several systems with different types of membranes and sizes. Pump-driven veno-venous systems generate fewer complications than do arteriovenous systems. Both require systemic anticoagulation. The "lung-kidney" support system, by combining a removal system with hemofiltration, simultaneously eliminates carbon dioxide and performs continuous extrarenal replacement. We describe our initial experience with a combined system for extracorporeal carbon dioxide removal-continuous extrarenal replacement in a lung transplant patients with hypercapnic respiratory failure, barotrauma and associated acute renal failure. The most important technical aspects, the effectiveness of the system for the elimination of carbon dioxide and a review of the literature are described.
近年来,部分由于技术进步,体外二氧化碳清除系统与体外膜肺氧合联合使用的情况再度出现。然而,缺乏确定其适应证和支持其使用的证据的研究。这些系统使用小口径插管(通常是具有小膜肺表面积的双腔插管)有效地清除高碳酸血症呼吸衰竭患者体内的二氧化碳。目前,我们有几种具有不同类型膜和尺寸的系统。泵驱动的静脉 - 静脉系统比动静脉系统产生的并发症更少。两者都需要全身抗凝。“肺 - 肾”支持系统通过将清除系统与血液滤过相结合,同时清除二氧化碳并进行持续的肾外替代治疗。我们描述了我们在一名患有高碳酸血症呼吸衰竭、气压伤和相关急性肾衰竭的肺移植患者中使用体外二氧化碳清除 - 持续肾外替代联合系统的初步经验。描述了最重要的技术方面、该系统清除二氧化碳的有效性以及文献综述。